Related Experiment Video
Updated: May 28, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Age-related mild cognitive deficit: a ready-to-use concept?
1Director of Research and Development, FORENAP, Rouffach, France.
Dialogues in Clinical Neuroscience
|October 29, 2011
Summary
Detecting mild cognitive impairment in elderly patients requires better tools for early diagnosis and progression prediction. Current criteria vary, impacting Alzheimer
Area of Science:
- Geriatric Medicine
- Neurology
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) management in the elderly necessitates reliable diagnostic and prognostic instruments.
- Existing MCI criteria exhibit variability in definition and application, leading to inconsistent prevalence rates.
- Neuropathological and follow-up studies highlight the heterogeneity of MCI progression and diagnostic accuracy.
Purpose of the Study:
- To review the challenges in defining and diagnosing mild cognitive impairment in elderly individuals.
- To evaluate the efficacy of current criteria in detecting early Alzheimer's disease (AD) and predicting dementia progression.
- To explore the potential of investigational techniques for early AD diagnosis.
Main Methods:
- Review of existing literature on mild cognitive impairment criteria and diagnostic tools.
- Analysis of neuropathological and longitudinal follow-up studies on MCI progression.
- Evaluation of investigational techniques including neuroimaging and biomarkers for AD detection.
Main Results:
- Current MCI criteria show variable power in detecting incipient Alzheimer's disease (AD) and predicting progression to dementia (2.5%-16.6% annual rate).
- Baseline cognitive performance has limited practical value in first-line medicine.
- Advanced investigational techniques like neuroimaging and biomarkers show promise for early AD diagnosis.
Conclusions:
- The criteria for mild cognitive deficit are currently difficult to implement in primary care settings.
- Disseminating awareness of MCI could improve general practitioners' sensitivity to cognitive complaints in the elderly.
- Early identification of patients progressing to dementia, particularly AD, is crucial for timely intervention, though treatment efficacy is under review.
More Related Videos
Related Concept Videos
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.